Global sterilization footprint Sterigenics operates a global network of 48 facilities across 13 countries, presenting opportunities to offer scalable, compliant sterilization capacity and redundancy for multinational medical device and pharmaceutical customers seeking reliable supply chains.

Expansion ripe Recent facility expansions including new x-ray sterilization capacity in the Southeast United States and growth into additional regions indicate a willingness to increase capacity and geographic reach, ideal for sales pitches centered on peak demand handling and regional compliance.

Diverse sterilization tech With capabilities in gamma, ethylene oxide, electron beam, X-ray and nitrogen dioxide, there is potential to tailor sterilization solutions for customers with varied product classes, reducing cycle times and meeting stringent regulatory requirements.

Regulatory risk focus Ongoing legal and regulatory scrutiny around ethylene oxide emissions presents a risk vector; position Sterigenics as a partner for compliant, risk-managed sterilization with robust environmental controls and transparent reporting to customers seeking compliance assurances.

Healthcare market momentum As global demand for sterile medical devices and pharmaceuticals grows, leverage Sterigenics’ global scale and safety branding to target mid to large manufacturers seeking validated sterilization partners to support growth, new product introductions, and geographic market expansion.